Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

University of Michigan claims new STAT-3 inhibitors

July 23, 2010

Enrollment begins in phase II MM-121 trial in breast cancer

July 23, 2010

Onyx begins phase III carfilzomib combination trial in relapsed multiple myeloma

July 22, 2010

Curis identifies novel CDK inhibitors

July 22, 2010

New PLK-1 inhibitors discovered by Rigel

July 22, 2010

Inotek describes novel PARP inhibitors

July 21, 2010

Aegera reports survival data from phase I AEG-35156 combination trial

July 21, 2010

German scientists disclose new HIF-mediated transcription inhibitors

July 21, 2010

CytRx advances its bafetinib program in oncology

July 21, 2010

Archer Biosciences begins dosing in third cohort of TPI-287 trial in metastatic melanoma

July 21, 2010

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...